Background illustration for clinical trials search

Paid Clinical Trials Indianapolis

Discover 901 paid clinical trials in Indianapolis, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Target Trial Emulation for Pharmacologic Treatment of Neonatal Opioid Withdrawal Syndrome

for
Neonatal Opioid Withdrawal Syndrome
Location: Indianapolis IN, Lexington KY, Birmingham AL,
Sponsor: HELP for NOWS Consortium

Sex: All

Age: 0+

Code: NCT07278375

Recruiting
Active & Responsive

Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia

for
Primary Ciliary Dyskinesia, Healthy
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 6+

Code: NCT07288827

Recruiting
Active & Responsive

Study of Cabozantinib With Selumetinib for Plexiform Neurofibromas

for
Neurofibromatosis 1, Plexiform Neurofibroma
Location: Indianapolis IN, Cincinnati OH, Birmingham AL,
Sponsor: Girish Dhall, MD

Sex: All

Age: 16+

Code: NCT06502171

Phase 1, Recruiting
Active & Responsive

Clinical Course Of Disease In Participants With FA-CM

for
Friedreich Ataxia, Cardiomyopathy
Location: Indianapolis IN, Cincinnati OH, St Louis MO,
Sponsor: Lexeo Therapeutics

Sex: All

Age: 6+

Code: NCT06865482

Recruiting
Active & Responsive

Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma

for
Pleuropulmonary Blastoma
Location: Indianapolis IN, Cincinnati OH, Dayton OH,
Sponsor: Children's Oncology Group

Sex: All

Age: 0 - 21

Code: NCT06647953

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)

for
PIK3CA-Related Overgrowth Spectrum (PROS),
Location: Indianapolis IN, Cincinnati OH, Grand Rapids MI,
Sponsor: Relay Therapeutics, Inc.

Sex: All

Age: 2+

Code: NCT06789913

Phase 2, Recruiting
Active & Responsive

Multi-site Study to Look at Tooth Wear and Tooth Sensitivity and the Risk Factors Associated.

for
Dentin Hypersensitivity, Erosive Tooth Wear
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT07195357

Recruiting
Active & Responsive

Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

for
Chronic Low Back Pain
Location: Indianapolis IN, St Louis MO, Asheville NC, Decatur GA,
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT04142177

Recruiting
Active & Responsive

A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events

for
Diabetes Mellitus, Type 2, PreDiabetes, Metabolic Syndrome
Location: Indianapolis IN, Edgewood KY, Louisville KY, Chicago IL,
Sponsor: Cleerly, Inc.

Sex: All

Age: 55+

Code: NCT06112418

Recruiting
Active & Responsive

Equipping Patients Using Interventions for Pain and Depression

for
Chronic Pain, Musculoskeletal Pain, Depression, Health Equity
Location: Indianapolis IN
Sponsor: Indiana University

Sex: All

Age: 18+

Code: NCT06500780

Recruiting
Active & Responsive

To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment

for
Chronic Obstructive Pulmonary Disease (COPD)
Location: Indianapolis IN, Columbus OH, Shelby NC, DuBois PA,
Sponsor: Expedition Therapeutics, Inc

Sex: All

Age: 40 - 70+

Code: NCT07684820

Phase 2, Recruiting
Active & Responsive

Prevalence of Antibodies and Cytokines in Participants With Chronic Granulomatous Disease

for
Chronic Granulomatous Disease (CGD)
Location: Indianapolis IN, Frankfort KY, Columbus OH,
Sponsor: Ensoma

Sex: All

Age: 0+

Code: NCT06605378

Recruiting
Active & Responsive

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

for
Intestinal Neoplasms, Gastrointestinal Neoplasms,
Location: Indianapolis IN, Mooresville IN, Fairfield OH,
Sponsor: Pfizer

Sex: All

Age: 18+

Code: NCT07222800

Phase 3, Recruiting
Active & Responsive

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

for
Cardiovascular Disease
Location: Indianapolis IN, Richmond IN, Cincinnati OH,
Sponsor: Amgen

Sex: All

Age: 50 - 70+

Code: NCT07136012

Phase 3, Recruiting
Active & Responsive

LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC

for
Metastatic Non-small Cell Lung Cancer
Location: Indianapolis IN, Fort Wayne IN, Elmhurst IL,
Sponsor: NovoCure GmbH

Sex: All

Age: 18+

Code: NCT06216301

Phase 3, Recruiting
Active & Responsive

CorMatrix Cor TRICUSPID ECM Valve Replacement Study

for
Tricuspid Valve Disease
Location: Indianapolis IN, Cincinnati OH, Baltimore MD, Mobile AL
Sponsor: CorMatrix Cardiovascular, Inc.

Sex: All

Age: 1 - 70+

Code: NCT02397668

Recruiting
Active & Responsive

A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)

for
Carcinoma, Non-Small-Cell Lung
Location: Indianapolis IN, Cincinnati OH, Chicago IL, Peoria IL,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06623422

Phase 3, Recruiting
Active & Responsive

A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)

for
Primary Myelofibrosis (PMF),
Location: Indianapolis IN, Chicago IL, Columbus OH, Atlanta GA,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18+

Code: NCT07357727

Phase 3, Recruiting
Active & Responsive

A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer

for
Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer,
Location: Indianapolis IN, Edgewood KY, Chicago IL, Ann Arbor MI,
Sponsor: Astellas Pharma Global Development, Inc.

Sex: All

Age: 18+

Code: NCT06901531

Phase 3, Recruiting
Active & Responsive

Study of Petosemtamab Plus Chemotherapy Versus Cetuximab Plus Chemotherapy in RAS and BRAF Wild-type, Unresectable or Metastatic, Left-sided Colorectal Cancer (LiGeR-CRC1)

for
Left-sided Colorectal Cancer
Location: Indianapolis IN, Springfield MO, Warner Robins GA,
Sponsor: Genmab

Sex: All

Age: 18+

Code: NCT07702032

Phase 3, Recruiting